China SXT Pharmaceuticals, Inc. Stock-Based Compensation
China SXT Pharmaceuticals, Inc. (SXTC) reported Stock-Based Compensation of $5.31 million for the 12-month period ending 2026-03-31, per its 20-F filed 2026-07-01.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-07-01
| Period end | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|
| 2026-03-31 | $5.31M 20-F · filed 2026-07-01 | |
| 2025-09-30 | $5.67M 6-K · filed 2025-12-31 | |
| 2024-03-31 | $352.10K 20-F · filed 2026-07-01 | |
| 2023-03-31 | $554.57K 20-F · filed 2025-07-31 | |
| 2022-03-31 | $2.33M 20-F · filed 2024-08-13 |